| Professional
Experience |
| Idaho State
University, Assistant Professor, 1964-1967 |
| University of
Iowa, College of Pharmacy, Assistant Professor, 1967-1969 |
| University of
Iowa, College of Pharmacy, Associate Professor, 1969-1974 |
| University
of Iowa, College of Pharmacy Professor, 1974- |
| Research |
| Dr. Barfknecht's
current research interests center on glaucoma drugs, agents for the
treatment of dry eye, and sigma ligands. |
| Representative
Publications |
| Schoenwald, R. D.; Vidvauns, S.; Wurster, D. E.; Barfknecht,
C. F., Tear film stability of protein extracts from dry eye patients
administered a sigma agonist, J. Ocular Pharmacol. 1997, 13,
151. |
| Schoenwald, R. D.; Vidvauns, S.; Wurster, D. E.; Barfknecht,
C. F., The influence of the proteins on tear film stability in
the rabbit, J. Ocular Pharmacol. Ther. 1998, 14, 15-29. |
| Schoenwald, R.D.; Yang, Y.S.; Xia, E.; Barfknecht, C.F.,
Uptake of N, N-dimethyl-2-phenylethylamine HC1 into Acini Cells Removed
fromRabbit Lacrimal Glands, J. Ocular Pharmacol. Ther. 1998, 14,
253-262 |
| Schoenwald, R.D.; Tandon, V.; Wurster, D.E.; Barfknecht, C.F.
Significance of melanin binding and metabolism in the activity of
5-acetoxyacetylimino-4-methyl-delta 2-1, 3, 4- thiadiazolin-2-sulfonamide,
Eur. J. Pharmaceutics Biopharm. 1998, 46, 39-50. |
| Representative
Patents |
| Schoenwald, R.D. & Barfknecht, C.F., Ocular Protein Stimulants,
U.S. Pat. 5,961,987 October 5, 1999. |
| Schoenwald, R.D. & Barfknecht, C.F., Lacrimal Secretion
Stimulant (LSS), Japanese Patent #, April 28, 1999. |
| Schoenwald, R.D. & Barfkencht, C.F., Tetrahydroquinoline
Analogues for Use n Glaucoma Treatment, U.S. Pat. 4,776, 482 July
7, 1998. |
| Schoenwald, R. D.; Barfknecht, C. F., Topical Use of Ethyl
Ethacrynate for Glaucoma Treatment, U. S. Patent 5,654,335 August
5,1997.
|
|